A Tale of Two Mutations: Beginning to Understand the Problems with Egg-Based Influenza Vaccines?
- PMID: 31194938
- DOI: 10.1016/j.chom.2019.05.012
A Tale of Two Mutations: Beginning to Understand the Problems with Egg-Based Influenza Vaccines?
Abstract
The majority of influenza vaccines are produced in embryonated eggs, but mutations occur as human influenza A(H3N2) viruses adapt to grow in eggs. This can alter virus antigenicity. Wu et al. (2019) reveal that there are two mutually exclusive pathways for egg adaptation, which has potential implications for future egg-based influenza vaccines.
Copyright © 2019. Published by Elsevier Inc.
Comment on
-
Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility.Cell Host Microbe. 2019 Jun 12;25(6):836-844.e5. doi: 10.1016/j.chom.2019.04.013. Epub 2019 May 28. Cell Host Microbe. 2019. PMID: 31151913 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical